Fundraising Fox

Adela

Foster City, US · Founded 2020 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

MJ
Maneesh JainDirector, Promoter
DD
Daniel Diniz De CarvalhoExecutive Officer, Promoter
AH
Anne-Renee HartmanExecutive Officer
AW
Alan WilliamsExecutive Officer
LA
Lisa AldersonExecutive Officer, Director
PH
Priscilla HuangExecutive Officer
KJ
Karla JarvisExecutive Officer
AH
Anne-Renee Hartman FeldmanExecutive Officer
SB
Scott BratmanExecutive Officer, Director
AE
Andrew ElBardissiDirector
DB
David BonitaDirector
PB
Paul BrownDirector

Investors · 2

Deerfield Management CompanyreportedNew Yorkvia Andrew ElBardissi · board
OrbiMedreportedNew York · $1M – $75Mvia David Bonita · board

Reported raises · per SEC filings

Form D private placements
▶$5MraisedApr 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert WeisskoffDirector
  • Alan WilliamsExecutive Officer
  • Daniel Diniz De CarvalhoExecutive Officer
  • Paul BrownDirector
  • Maneesh JainDirector
  • David ScheerExecutive Officer, Director
  • Abraham KometzDirector
  • David BonitaDirector
  • Scott BratmanExecutive Officer
  • Anne-Renee HartmanExecutive Officer
  • Lisa AldersonExecutive Officer, Director
  • Lindsay MateoExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.4MraisedJul 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lisa AldersonExecutive Officer, Director
  • Anne-Renee HartmanExecutive Officer
  • Andrew ElBardissiDirector
  • David BonitaDirector
  • Maneesh JainDirector, Promoter
  • Robert WeisskoffDirector
  • Paul BrownDirector
  • Daniel Diniz De CarvalhoExecutive Officer, Promoter
  • Alan WilliamsExecutive Officer
  • David ScheerExecutive Officer, Director, Promoter
  • Priscilla HuangExecutive Officer
Offering amount
$27M
Amount sold
$25.4M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.5MraisedJul 2024 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ElBardissiDirector
  • David BonitaDirector
  • Paul BrownDirector
  • Anne-Renee HartmanExecutive Officer
  • Alan WilliamsExecutive Officer
  • David ScheerExecutive Officer, Director, Promoter
  • Lisa AldersonExecutive Officer, Director
  • Priscilla HuangExecutive Officer
  • Karla JarvisExecutive Officer
  • Robert WeisskoffDirector
  • Maneesh JainDirector, Promoter
  • Daniel Diniz De CarvalhoExecutive Officer, Promoter
Offering amount
$49.3M
Amount sold
$48.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedFeb 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ElBardissiDirector
  • Daniel Diniz De CarvalhoExecutive Officer, Promoter
  • Maneesh JainDirector, Promoter
  • Anne-Renee HartmanExecutive Officer
  • Priscilla HuangExecutive Officer
  • Robert WeisskoffDirector
  • Lisa AldersonExecutive Officer, Director
  • Alan WilliamsExecutive Officer
  • Paul BrownDirector
  • David ScheerExecutive Officer, Director, Promoter
  • David BonitaDirector
  • Karla JarvisExecutive Officer
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedFeb 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David ScheerExecutive Officer, Director, Promoter
  • Andrew ElBardissiDirector
  • Lisa AldersonExecutive Officer, Director
  • David BonitaDirector
  • Karla JarvisExecutive Officer
  • Anne-Renee HartmanExecutive Officer
  • Maneesh JainDirector, Promoter
  • Robert WeisskoffDirector
  • Alan WilliamsExecutive Officer
  • Daniel Diniz De CarvalhoExecutive Officer, Promoter
  • Paul BrownDirector
  • Priscilla HuangExecutive Officer
Offering amount
$3.3M
Amount sold
$3.3M
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedMar 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anne-Renee Hartman FeldmanExecutive Officer
  • Daniel De CarvalhoExecutive Officer
  • Maneesh JainDirector
  • Scott BratmanExecutive Officer, Director
  • David ScheerDirector
Offering amount
$60M
Amount sold
$30M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.